title: To screen or not to screen: ongoing debate in the early detection of prostate cancer.
abstract: Debate about the use of prostate-specific antigen (PSA) tests to screen prostate cancer in men is ongoing. Prostate cancer is the most common cancer after skin cancer in men and the second most deadly after lung cancer. An elevated PSA level can lead to this cancer's diagnosis and treatment even before the onset of symptoms. However, other causes also can create a high PSA level, which may lead to men being unnecessarily treated for prostate cancer. This article will shed some light on the issue and discuss prostate cancer screening.
authors.affiliation: Department of Nursing, University of Pennsylvania, Philadelphia, USA. riemarroquin@gmail.com
authors.forename: Joanna Marie
authors.initials: JM
authors.lastname: Marroquin
mesh_terms: D003657:Decision Making; D042241:Early Diagnosis; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis*; D012680:Sensitivity and Specificity
chemical_list: D017430:Prostate-Specific Antigen